Moderna Inc (MRNA)

Receivables turnover

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Revenue (ttm) US$ in thousands 3,229,000 5,076,000 5,052,000 5,155,000 6,826,000 9,097,000 10,486,000 14,708,000 18,810,000 20,675,000 22,284,000 21,933,000 17,736,000 11,016,375 6,199,591 2,013,033 274,490 55,668 56,790 38,378
Receivables US$ in thousands
Receivables turnover

December 31, 2024 calculation

Receivables turnover = Revenue (ttm) ÷ Receivables
= $3,229,000K ÷ $—K
= —

The data provided for Moderna Inc's receivables turnover ratio shows "—", indicating that specific values for receivables turnover are not available for each reporting period from March 31, 2020, to December 31, 2024.

Receivables turnover ratio is a financial metric that measures how efficiently a company is collecting its outstanding receivables during a specific period. It is calculated by dividing net credit sales by the average accounts receivable balance. A higher turnover ratio suggests that the company is collecting its receivables more quickly, which is generally seen as a positive indicator of effective credit management and liquidity.

In the absence of specific data points for Moderna Inc's receivables turnover, it is challenging to assess the company's efficiency in collecting its accounts receivable over time. Without this information, it becomes difficult to gauge the impact of changes in the company's credit policy, customer payment behaviors, or overall business performance on the effectiveness of its receivables management.

As such, without the actual values for the receivables turnover ratio, a detailed analysis or trend analysis of Moderna Inc's receivables turnover is not feasible based on the provided data points.


See also:

Moderna Inc Receivables Turnover (Quarterly Data)